

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gonadal mesoderm development (GO:0007506) | 6.45792041 |
| 2 | glomerulus development (GO:0032835) | 6.24103310 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 5.91844169 |
| 4 | lung vasculature development (GO:0060426) | 5.10665981 |
| 5 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 5.09190432 |
| 6 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 5.09190432 |
| 7 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 5.02996122 |
| 8 | muscle hypertrophy in response to stress (GO:0003299) | 5.02996122 |
| 9 | cardiac muscle adaptation (GO:0014887) | 5.02996122 |
| 10 | protein heterotrimerization (GO:0070208) | 4.89733928 |
| 11 | respiratory tube development (GO:0030323) | 4.85588443 |
| 12 | cardiac muscle hypertrophy (GO:0003300) | 4.84330106 |
| 13 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.73704973 |
| 14 | cell differentiation involved in metanephros development (GO:0072202) | 4.61847410 |
| 15 | striated muscle hypertrophy (GO:0014897) | 4.59675572 |
| 16 | white fat cell differentiation (GO:0050872) | 4.52849766 |
| 17 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.48425729 |
| 18 | glomerular filtration (GO:0003094) | 4.40665020 |
| 19 | carnitine shuttle (GO:0006853) | 4.25041424 |
| 20 | diaphragm development (GO:0060539) | 4.23696932 |
| 21 | myofibril assembly (GO:0030239) | 4.16775263 |
| 22 | atrioventricular valve morphogenesis (GO:0003181) | 4.15094712 |
| 23 | fatty acid transmembrane transport (GO:1902001) | 4.14215126 |
| 24 | sex determination (GO:0007530) | 4.08845458 |
| 25 | muscle filament sliding (GO:0030049) | 4.07603854 |
| 26 | actin-myosin filament sliding (GO:0033275) | 4.07603854 |
| 27 | potassium ion import (GO:0010107) | 4.05474165 |
| 28 | muscle hypertrophy (GO:0014896) | 4.04259463 |
| 29 | renal filtration (GO:0097205) | 4.01115241 |
| 30 | regulation of actin filament-based movement (GO:1903115) | 3.90673493 |
| 31 | cGMP-mediated signaling (GO:0019934) | 3.90210940 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.89282300 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.86519196 |
| 34 | metanephric mesenchyme development (GO:0072075) | 3.85740897 |
| 35 | glomerular basement membrane development (GO:0032836) | 3.84300164 |
| 36 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.74663263 |
| 37 | brown fat cell differentiation (GO:0050873) | 3.72954908 |
| 38 | cGMP biosynthetic process (GO:0006182) | 3.70830155 |
| 39 | Notch signaling involved in heart development (GO:0061314) | 3.68467812 |
| 40 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.62410620 |
| 41 | skeletal muscle organ development (GO:0060538) | 3.60981646 |
| 42 | actin-mediated cell contraction (GO:0070252) | 3.57214752 |
| 43 | cardiac cell development (GO:0055006) | 3.53744239 |
| 44 | cell proliferation involved in metanephros development (GO:0072203) | 3.51052681 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.50661543 |
| 46 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.49758573 |
| 47 | kidney mesenchyme development (GO:0072074) | 3.49552780 |
| 48 | cardiac right ventricle morphogenesis (GO:0003215) | 3.47804543 |
| 49 | carnitine transmembrane transport (GO:1902603) | 3.47634831 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.47423916 |
| 51 | sarcomere organization (GO:0045214) | 3.47394520 |
| 52 | extracellular matrix assembly (GO:0085029) | 3.42813229 |
| 53 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.42077103 |
| 54 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.38204539 |
| 55 | positive regulation of fatty acid oxidation (GO:0046321) | 3.35400493 |
| 56 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.34768061 |
| 57 | biotin metabolic process (GO:0006768) | 3.33220176 |
| 58 | cell migration involved in heart development (GO:0060973) | 3.33170686 |
| 59 | relaxation of smooth muscle (GO:0044557) | 3.32328340 |
| 60 | cardiac muscle cell development (GO:0055013) | 3.31739516 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31606829 |
| 62 | lipid particle organization (GO:0034389) | 3.31267653 |
| 63 | relaxation of muscle (GO:0090075) | 3.29751411 |
| 64 | triglyceride catabolic process (GO:0019433) | 3.29041810 |
| 65 | positive regulation of metanephros development (GO:0072216) | 3.28145331 |
| 66 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.27095851 |
| 67 | cell proliferation involved in kidney development (GO:0072111) | 3.26592688 |
| 68 | lymph vessel development (GO:0001945) | 3.26523738 |
| 69 | striated muscle adaptation (GO:0014888) | 3.25409392 |
| 70 | heart valve morphogenesis (GO:0003179) | 3.24125821 |
| 71 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.23661549 |
| 72 | positive regulation of male gonad development (GO:2000020) | 3.20904041 |
| 73 | regulation of skeletal muscle contraction (GO:0014819) | 3.20236425 |
| 74 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.17729620 |
| 75 | ventricular cardiac muscle cell development (GO:0055015) | 3.17038198 |
| 76 | induction of positive chemotaxis (GO:0050930) | 3.17010524 |
| 77 | fibroblast migration (GO:0010761) | 3.16500966 |
| 78 | smooth muscle tissue development (GO:0048745) | 3.16310550 |
| 79 | aorta morphogenesis (GO:0035909) | 3.16043424 |
| 80 | dermatan sulfate biosynthetic process (GO:0030208) | 3.16024279 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.14513046 |
| 82 | carnitine transport (GO:0015879) | 3.14513046 |
| 83 | cell communication by electrical coupling (GO:0010644) | 3.13645405 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.11534981 |
| 85 | cell-substrate adherens junction assembly (GO:0007045) | 3.11477979 |
| 86 | focal adhesion assembly (GO:0048041) | 3.11477979 |
| 87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.10687290 |
| 88 | cardiac muscle contraction (GO:0060048) | 3.10061340 |
| 89 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.09269361 |
| 90 | smooth muscle cell differentiation (GO:0051145) | 3.08047484 |
| 91 | mesenchyme morphogenesis (GO:0072132) | 3.07506473 |
| 92 | positive regulation of catenin import into nucleus (GO:0035413) | 3.06942848 |
| 93 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.06453464 |
| 94 | endothelium development (GO:0003158) | 3.04277650 |
| 95 | heart trabecula formation (GO:0060347) | 3.02538490 |
| 96 | regulation of cardioblast differentiation (GO:0051890) | 3.01527470 |
| 97 | extracellular fibril organization (GO:0043206) | 2.98803816 |
| 98 | adherens junction assembly (GO:0034333) | 2.98801379 |
| 99 | endocardial cushion morphogenesis (GO:0003203) | 2.97665852 |
| 100 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.97532368 |
| 101 | actomyosin structure organization (GO:0031032) | 2.95335485 |
| 102 | limb bud formation (GO:0060174) | 2.94305663 |
| 103 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.94288010 |
| 104 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.93242951 |
| 105 | germ cell migration (GO:0008354) | 2.92755354 |
| 106 | cellular hyperosmotic response (GO:0071474) | 2.92052483 |
| 107 | dermatan sulfate metabolic process (GO:0030205) | 2.92010521 |
| 108 | adult heart development (GO:0007512) | 2.91919926 |
| 109 | sodium ion export (GO:0071436) | 2.90678151 |
| 110 | cGMP metabolic process (GO:0046068) | 2.89221489 |
| 111 | lung morphogenesis (GO:0060425) | 2.89201502 |
| 112 | triglyceride biosynthetic process (GO:0019432) | 2.88708027 |
| 113 | myelination in peripheral nervous system (GO:0022011) | 2.88062032 |
| 114 | peripheral nervous system axon ensheathment (GO:0032292) | 2.88062032 |
| 115 | lymphangiogenesis (GO:0001946) | 2.87798510 |
| 116 | acylglycerol biosynthetic process (GO:0046463) | 2.87381471 |
| 117 | neutral lipid biosynthetic process (GO:0046460) | 2.87381471 |
| 118 | cell volume homeostasis (GO:0006884) | 2.86605409 |
| 119 | positive regulation of heart growth (GO:0060421) | 2.83891808 |
| 120 | mesenchymal cell development (GO:0014031) | 2.83451792 |
| 121 | regulation of cholesterol storage (GO:0010885) | 2.81904971 |
| 122 | growth hormone receptor signaling pathway (GO:0060396) | 2.81839421 |
| 123 | regulation of fatty acid oxidation (GO:0046320) | 2.81720036 |
| 124 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.81068407 |
| 125 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.80598840 |
| 126 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.80391003 |
| 127 | muscle contraction (GO:0006936) | 2.80335049 |
| 128 | tonic smooth muscle contraction (GO:0014820) | 2.79135009 |
| 129 | cyclic nucleotide catabolic process (GO:0009214) | 2.78493121 |
| 130 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.78400706 |
| 131 | regulation of male gonad development (GO:2000018) | 2.77987638 |
| 132 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.76994770 |
| 133 | import into cell (GO:0098657) | 2.76981385 |
| 134 | striated muscle contraction (GO:0006941) | 2.76243533 |
| 135 | ovulation from ovarian follicle (GO:0001542) | 2.75321054 |
| 136 | relaxation of cardiac muscle (GO:0055119) | 2.74842025 |
| 137 | muscle system process (GO:0003012) | 2.74377133 |
| 138 | thioester biosynthetic process (GO:0035384) | 2.74040340 |
| 139 | acyl-CoA biosynthetic process (GO:0071616) | 2.74040340 |
| 140 | valine metabolic process (GO:0006573) | 2.73566988 |
| 141 | neutral lipid catabolic process (GO:0046461) | 2.72417716 |
| 142 | acylglycerol catabolic process (GO:0046464) | 2.72417716 |
| 143 | basement membrane organization (GO:0071711) | 2.72397934 |
| 144 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.71771395 |
| 145 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.71497560 |
| 146 | astrocyte development (GO:0014002) | 2.71127966 |
| 147 | atrial septum morphogenesis (GO:0060413) | 2.70335013 |
| 148 | paraxial mesoderm development (GO:0048339) | 2.69921678 |
| 149 | SMAD protein signal transduction (GO:0060395) | 2.69207304 |
| 150 | membrane raft organization (GO:0031579) | 2.68972299 |
| 151 | quaternary ammonium group transport (GO:0015697) | 2.67656939 |
| 152 | regulation of smooth muscle cell migration (GO:0014910) | 2.67513803 |
| 153 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.67124152 |
| 154 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.66419915 |
| 155 | myelin maintenance (GO:0043217) | 2.66391803 |
| 156 | cyclic nucleotide biosynthetic process (GO:0009190) | 2.65395580 |
| 157 | actin filament-based movement (GO:0030048) | 2.65281230 |
| 158 | negative regulation of muscle contraction (GO:0045932) | 2.65279614 |
| 159 | regulation of endothelial cell differentiation (GO:0045601) | 2.65194281 |
| 160 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.64843822 |
| 161 | cAMP catabolic process (GO:0006198) | 2.64671106 |
| 162 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.64550522 |
| 163 | regulation of cell communication by electrical coupling (GO:0010649) | 2.64290989 |
| 164 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.64081040 |
| 165 | positive regulation of calcium ion import (GO:0090280) | 2.63660066 |
| 166 | cardiac myofibril assembly (GO:0055003) | 2.62498463 |
| 167 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.62275137 |
| 168 | regulation of striated muscle contraction (GO:0006942) | 2.61899393 |
| 169 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.61500041 |
| 170 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.60319971 |
| 171 | gamma-aminobutyric acid transport (GO:0015812) | 2.58874043 |
| 172 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.58798761 |
| 173 | embryonic digestive tract morphogenesis (GO:0048557) | 2.58566027 |
| 174 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.58274067 |
| 175 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.55998880 |
| 176 | positive regulation of macrophage cytokine production (GO:0060907) | 2.55815302 |
| 177 | phagocytosis, recognition (GO:0006910) | 2.55108900 |
| 178 | neural crest cell development (GO:0014032) | 2.53458219 |
| 179 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.53327773 |
| 180 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.52012386 |
| 181 | cellular response to growth hormone stimulus (GO:0071378) | 2.50774674 |
| 182 | regulation of gonadotropin secretion (GO:0032276) | 2.50247140 |
| 183 | branched-chain amino acid catabolic process (GO:0009083) | 2.49575551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.48202550 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.11503333 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.81168724 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.59120256 |
| 5 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.52529718 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.43931617 |
| 7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.40530208 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38040667 |
| 9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.33909312 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22774914 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16453501 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10405655 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05422342 |
| 14 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.03962596 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.03180798 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.93045512 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89506762 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88635357 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88635357 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86231711 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86223696 |
| 22 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.85712013 |
| 23 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.82869907 |
| 24 | CJUN_26792858_Chip-Seq_BT549_Human | 1.81558393 |
| 25 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.78425049 |
| 26 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76494236 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76467493 |
| 28 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.73395406 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70756918 |
| 30 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68831312 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68774885 |
| 32 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65640325 |
| 33 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64157140 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.61787951 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61621958 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58999945 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57521479 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.53234520 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44861571 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44725952 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43484789 |
| 42 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40162115 |
| 43 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.38825599 |
| 44 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.38825599 |
| 45 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.38825599 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38043479 |
| 47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.37562836 |
| 48 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.37562836 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37145255 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37145255 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35507208 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.35332604 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33869474 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32852674 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31971597 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.31398563 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30456855 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29599080 |
| 59 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.29454211 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29260192 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27770496 |
| 62 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.27553109 |
| 63 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.25400968 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24964743 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23850051 |
| 66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23386290 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23257176 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23028334 |
| 69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.21551117 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20499659 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19596808 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18924241 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18731638 |
| 74 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.18588951 |
| 75 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.18209669 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.17752722 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17720293 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17402618 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17378036 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17130138 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16828418 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14939265 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14729483 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14426875 |
| 85 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.14004819 |
| 86 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12212243 |
| 87 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11298173 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11171927 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.10193217 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10071564 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10044938 |
| 92 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07125259 |
| 93 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06777746 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06547474 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06302473 |
| 96 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.05779939 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05693548 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03996095 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03381844 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02096448 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01999997 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01766104 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01107238 |
| 104 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99635470 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99005165 |
| 106 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97681565 |
| 107 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96856026 |
| 108 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.96849325 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94387650 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92232267 |
| 111 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91689325 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91628379 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91025220 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90659860 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90203214 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89886800 |
| 117 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89379550 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88533972 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87796411 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86535598 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85362560 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84309832 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.82267732 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81586957 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80677213 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79982463 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79564257 |
| 128 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79203937 |
| 129 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79203937 |
| 130 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79166646 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79093388 |
| 132 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.77570974 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77532418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.11340426 |
| 2 | MP0005670_abnormal_white_adipose | 5.02642810 |
| 3 | MP0004272_abnormal_basement_membrane | 3.66266925 |
| 4 | MP0000013_abnormal_adipose_tissue | 3.61623249 |
| 5 | MP0005666_abnormal_adipose_tissue | 3.49353089 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 3.46754389 |
| 7 | MP0004130_abnormal_muscle_cell | 3.24529485 |
| 8 | MP0005375_adipose_tissue_phenotype | 2.97388738 |
| 9 | MP0000003_abnormal_adipose_tissue | 2.72552691 |
| 10 | MP0003646_muscle_fatigue | 2.63402275 |
| 11 | MP0005275_abnormal_skin_tensile | 2.62702189 |
| 12 | MP0008995_early_reproductive_senescence | 2.47816888 |
| 13 | MP0001661_extended_life_span | 2.46730237 |
| 14 | MP0001879_abnormal_lymphatic_vessel | 2.46363782 |
| 15 | MP0001958_emphysema | 2.42320256 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.39185165 |
| 17 | MP0006138_congestive_heart_failure | 2.34131260 |
| 18 | MP0005623_abnormal_meninges_morphology | 2.27432574 |
| 19 | MP0003279_aneurysm | 2.27345524 |
| 20 | MP0002295_abnormal_pulmonary_circulatio | 2.25517519 |
| 21 | MP0002009_preneoplasia | 2.25308950 |
| 22 | MP0000751_myopathy | 2.13895958 |
| 23 | MP0010368_abnormal_lymphatic_system | 2.03692813 |
| 24 | MP0003724_increased_susceptibility_to | 1.98975433 |
| 25 | MP0003828_pulmonary_edema | 1.97497480 |
| 26 | MP0003283_abnormal_digestive_organ | 1.93761385 |
| 27 | MP0002971_abnormal_brown_adipose | 1.79231072 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.75935857 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.74245709 |
| 30 | MP0005369_muscle_phenotype | 1.72994233 |
| 31 | MP0002106_abnormal_muscle_physiology | 1.72805491 |
| 32 | MP0002102_abnormal_ear_morphology | 1.70961378 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.64683010 |
| 34 | MP0005595_abnormal_vascular_smooth | 1.59917206 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.56605995 |
| 36 | MP0002269_muscular_atrophy | 1.55287755 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.55084260 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.48955886 |
| 39 | MP0003119_abnormal_digestive_system | 1.48835951 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.47807686 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.47541490 |
| 42 | MP0004084_abnormal_cardiac_muscle | 1.43883025 |
| 43 | MP0000747_muscle_weakness | 1.42942423 |
| 44 | MP0003045_fibrosis | 1.42440115 |
| 45 | MP0000767_abnormal_smooth_muscle | 1.39698418 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.37826531 |
| 47 | MP0005330_cardiomyopathy | 1.33988865 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.33357358 |
| 49 | MP0005385_cardiovascular_system_phenoty | 1.32939889 |
| 50 | MP0001544_abnormal_cardiovascular_syste | 1.32939889 |
| 51 | MP0002254_reproductive_system_inflammat | 1.31021717 |
| 52 | MP0004134_abnormal_chest_morphology | 1.27772261 |
| 53 | MP0000343_altered_response_to | 1.27283464 |
| 54 | MP0005164_abnormal_response_to | 1.24183369 |
| 55 | MP0009115_abnormal_fat_cell | 1.24173497 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.22368707 |
| 57 | MP0000750_abnormal_muscle_regeneration | 1.20735548 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.20022181 |
| 59 | MP0005171_absent_coat_pigmentation | 1.18305066 |
| 60 | MP0002133_abnormal_respiratory_system | 1.17910690 |
| 61 | MP0005388_respiratory_system_phenotype | 1.17910690 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.17796613 |
| 63 | MP0000230_abnormal_systemic_arterial | 1.17442519 |
| 64 | MP0004270_analgesia | 1.12891834 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.12227471 |
| 66 | MP0003136_yellow_coat_color | 1.08346080 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.07336689 |
| 68 | MP0002128_abnormal_blood_circulation | 1.06641166 |
| 69 | MP0003091_abnormal_cell_migration | 1.05034150 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.04988573 |
| 71 | MP0004147_increased_porphyrin_level | 1.02999664 |
| 72 | MP0005334_abnormal_fat_pad | 1.02629999 |
| 73 | MP0003115_abnormal_respiratory_system | 1.02387112 |
| 74 | MP0000049_abnormal_middle_ear | 1.01257968 |
| 75 | MP0003878_abnormal_ear_physiology | 1.00275400 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 1.00275400 |
| 77 | MP0006054_spinal_hemorrhage | 0.98719920 |
| 78 | MP0009250_abnormal_appendicular_skeleto | 0.98690241 |
| 79 | MP0000534_abnormal_ureter_morphology | 0.98342551 |
| 80 | MP0000733_abnormal_muscle_development | 0.97501285 |
| 81 | MP0002925_abnormal_cardiovascular_devel | 0.97105015 |
| 82 | MP0000266_abnormal_heart_morphology | 0.95099574 |
| 83 | MP0005165_increased_susceptibility_to | 0.93968681 |
| 84 | MP0004484_altered_response_of | 0.92880312 |
| 85 | MP0003690_abnormal_glial_cell | 0.91348414 |
| 86 | MP0009278_abnormal_bone_marrow | 0.90460606 |
| 87 | MP0000749_muscle_degeneration | 0.90123263 |
| 88 | MP0000249_abnormal_blood_vessel | 0.89938547 |
| 89 | MP0002168_other_aberrant_phenotype | 0.89820749 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.89327296 |
| 91 | MP0002132_abnormal_respiratory_system | 0.88896313 |
| 92 | MP0008004_abnormal_stomach_pH | 0.88569983 |
| 93 | MP0000537_abnormal_urethra_morphology | 0.88332191 |
| 94 | MP0000516_abnormal_urinary_system | 0.88084014 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.88084014 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.87725539 |
| 97 | MP0001177_atelectasis | 0.87682127 |
| 98 | MP0005535_abnormal_body_temperature | 0.87321944 |
| 99 | MP0004510_myositis | 0.87065887 |
| 100 | MP0001614_abnormal_blood_vessel | 0.86237728 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.86038867 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.83982439 |
| 103 | MP0004742_abnormal_vestibular_system | 0.82402243 |
| 104 | MP0000462_abnormal_digestive_system | 0.82241798 |
| 105 | MP0002108_abnormal_muscle_morphology | 0.81875614 |
| 106 | MP0000163_abnormal_cartilage_morphology | 0.80670803 |
| 107 | MP0005508_abnormal_skeleton_morphology | 0.78954027 |
| 108 | MP0000920_abnormal_myelination | 0.78290655 |
| 109 | MP0002734_abnormal_mechanical_nocicepti | 0.76835489 |
| 110 | MP0002933_joint_inflammation | 0.76741674 |
| 111 | MP0002060_abnormal_skin_morphology | 0.76620050 |
| 112 | MP0004233_abnormal_muscle_weight | 0.76121859 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.75657095 |
| 114 | MP0003948_abnormal_gas_homeostasis | 0.75183258 |
| 115 | MP0003935_abnormal_craniofacial_develop | 0.74670361 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.73320505 |
| 117 | MP0000428_abnormal_craniofacial_morphol | 0.73259781 |
| 118 | MP0002006_tumorigenesis | 0.72681665 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.72572717 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.72241750 |
| 121 | MP0004085_abnormal_heartbeat | 0.72094478 |
| 122 | MP0004133_heterotaxia | 0.70762877 |
| 123 | MP0003942_abnormal_urinary_system | 0.70740333 |
| 124 | MP0002249_abnormal_larynx_morphology | 0.69908853 |
| 125 | MP0002282_abnormal_trachea_morphology | 0.68183927 |
| 126 | MP0009780_abnormal_chondrocyte_physiolo | 0.67775122 |
| 127 | MP0001664_abnormal_digestion | 0.67172850 |
| 128 | MP0003191_abnormal_cellular_cholesterol | 0.67038594 |
| 129 | MP0001175_abnormal_lung_morphology | 0.66854036 |
| 130 | MP0002970_abnormal_white_adipose | 0.66805869 |
| 131 | MP0004883_abnormal_blood_vessel | 0.64446566 |
| 132 | MP0001984_abnormal_olfaction | 0.63962135 |
| 133 | MP0003385_abnormal_body_wall | 0.63897337 |
| 134 | MP0004145_abnormal_muscle_electrophysio | 0.63590027 |
| 135 | MP0008569_lethality_at_weaning | 0.63230734 |
| 136 | MP0003941_abnormal_skin_development | 0.63135835 |
| 137 | MP0004858_abnormal_nervous_system | 0.62988961 |
| 138 | MP0001542_abnormal_bone_strength | 0.62679166 |
| 139 | MP0002127_abnormal_cardiovascular_syste | 0.62455640 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.61923139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aortic dissection (HP:0002647) | 5.11859662 |
| 2 | Aortic aneurysm (HP:0004942) | 4.92996637 |
| 3 | Ankle contracture (HP:0006466) | 4.70188446 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.64761982 |
| 5 | Nemaline bodies (HP:0003798) | 4.59197344 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.52686184 |
| 7 | Broad metatarsal (HP:0001783) | 4.49710642 |
| 8 | Increased variability in muscle fiber diameter (HP:0003557) | 4.25982984 |
| 9 | Bone cyst (HP:0012062) | 4.18151372 |
| 10 | Premature rupture of membranes (HP:0001788) | 4.07225725 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 3.88917418 |
| 12 | Facial diplegia (HP:0001349) | 3.75824557 |
| 13 | Spinal rigidity (HP:0003306) | 3.75400370 |
| 14 | Oligomenorrhea (HP:0000876) | 3.74264791 |
| 15 | Pulmonary artery stenosis (HP:0004415) | 3.73385942 |
| 16 | Bundle branch block (HP:0011710) | 3.62089227 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.61227406 |
| 18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.58102616 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.52614337 |
| 20 | Short hallux (HP:0010109) | 3.51503720 |
| 21 | Stridor (HP:0010307) | 3.51347962 |
| 22 | Exercise-induced muscle cramps (HP:0003710) | 3.43354541 |
| 23 | Acanthosis nigricans (HP:0000956) | 3.42753054 |
| 24 | Hypoplasia of the iris (HP:0007676) | 3.38106586 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 3.37934111 |
| 26 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.25523313 |
| 27 | Nausea (HP:0002018) | 3.24677161 |
| 28 | Distal arthrogryposis (HP:0005684) | 3.17243888 |
| 29 | Cerebral aneurysm (HP:0004944) | 3.14897140 |
| 30 | Follicular hyperkeratosis (HP:0007502) | 3.02211599 |
| 31 | Protrusio acetabuli (HP:0003179) | 2.99966736 |
| 32 | Supraventricular arrhythmia (HP:0005115) | 2.97400971 |
| 33 | Mesangial abnormality (HP:0001966) | 2.95287245 |
| 34 | Gonadal dysgenesis (HP:0000133) | 2.94837960 |
| 35 | Vertebral arch anomaly (HP:0008438) | 2.92764422 |
| 36 | Primary atrial arrhythmia (HP:0001692) | 2.90301364 |
| 37 | Increased connective tissue (HP:0009025) | 2.85884405 |
| 38 | Prominent supraorbital ridges (HP:0000336) | 2.84007430 |
| 39 | Round ear (HP:0100830) | 2.81955365 |
| 40 | Abnormality of the ischium (HP:0003174) | 2.80042907 |
| 41 | Bladder diverticulum (HP:0000015) | 2.75155303 |
| 42 | Supraventricular tachycardia (HP:0004755) | 2.75100381 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.74962430 |
| 44 | Muscle fiber splitting (HP:0003555) | 2.72196581 |
| 45 | Soft skin (HP:0000977) | 2.69205815 |
| 46 | Difficulty running (HP:0009046) | 2.64858388 |
| 47 | Gonadotropin excess (HP:0000837) | 2.63797726 |
| 48 | Subaortic stenosis (HP:0001682) | 2.60810573 |
| 49 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60810573 |
| 50 | Heart block (HP:0012722) | 2.54226121 |
| 51 | Periauricular skin pits (HP:0100277) | 2.52948974 |
| 52 | Preauricular pit (HP:0004467) | 2.52948974 |
| 53 | Aortic regurgitation (HP:0001659) | 2.48709677 |
| 54 | Slender build (HP:0001533) | 2.48168384 |
| 55 | Neoplasm of the heart (HP:0100544) | 2.46757334 |
| 56 | Hypoplastic heart (HP:0001961) | 2.45519494 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.42428541 |
| 58 | Premature skin wrinkling (HP:0100678) | 2.41553908 |
| 59 | Bell-shaped thorax (HP:0001591) | 2.41403239 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.39958608 |
| 61 | Myoglobinuria (HP:0002913) | 2.39178572 |
| 62 | Venous insufficiency (HP:0005293) | 2.39124994 |
| 63 | Venous abnormality (HP:0002624) | 2.38906143 |
| 64 | Hypertriglyceridemia (HP:0002155) | 2.37235794 |
| 65 | Preaxial foot polydactyly (HP:0001841) | 2.36196689 |
| 66 | Lipoatrophy (HP:0100578) | 2.35529140 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.33805033 |
| 68 | Muscle stiffness (HP:0003552) | 2.30488577 |
| 69 | Skin pits (HP:0100276) | 2.30125677 |
| 70 | Scapular winging (HP:0003691) | 2.29838305 |
| 71 | Hypoplastic left heart (HP:0004383) | 2.26944563 |
| 72 | Limited hip movement (HP:0008800) | 2.25434993 |
| 73 | Cerebral hemorrhage (HP:0001342) | 2.25009602 |
| 74 | Hyporeflexia of lower limbs (HP:0002600) | 2.24436963 |
| 75 | Overgrowth (HP:0001548) | 2.24143875 |
| 76 | Coronal craniosynostosis (HP:0004440) | 2.23562114 |
| 77 | Rectal prolapse (HP:0002035) | 2.22939922 |
| 78 | Myopathic facies (HP:0002058) | 2.22318532 |
| 79 | Rimmed vacuoles (HP:0003805) | 2.20285760 |
| 80 | Lymphangioma (HP:0100764) | 2.19276022 |
| 81 | Hematochezia (HP:0002573) | 2.18229979 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18006841 |
| 83 | Fibular hypoplasia (HP:0003038) | 2.17237377 |
| 84 | Myotonia (HP:0002486) | 2.16645497 |
| 85 | Syncope (HP:0001279) | 2.15140724 |
| 86 | Male infertility (HP:0003251) | 2.14357991 |
| 87 | Abnormality of dentin (HP:0010299) | 2.14139592 |
| 88 | Hyperglycinuria (HP:0003108) | 2.14082309 |
| 89 | Neonatal short-limb short stature (HP:0008921) | 2.13304072 |
| 90 | Exercise-induced myalgia (HP:0003738) | 2.13085387 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.11954482 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11954482 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.10733891 |
| 94 | Ulnar claw (HP:0001178) | 2.08267115 |
| 95 | Scotoma (HP:0000575) | 2.07296990 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.06648455 |
| 97 | Right ventricular cardiomyopathy (HP:0011663) | 2.06337694 |
| 98 | Atrioventricular block (HP:0001678) | 2.05330274 |
| 99 | Hip contracture (HP:0003273) | 2.02666710 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02368602 |
| 101 | Aplasia involving bones of the extremities (HP:0009825) | 2.02368602 |
| 102 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02368602 |
| 103 | Prolonged QT interval (HP:0001657) | 2.02078705 |
| 104 | Long toe (HP:0010511) | 2.01230391 |
| 105 | Bulbar palsy (HP:0001283) | 2.00184973 |
| 106 | Atrophic scars (HP:0001075) | 1.99673432 |
| 107 | Muscular dystrophy (HP:0003560) | 1.98558366 |
| 108 | Growth hormone excess (HP:0000845) | 1.98204087 |
| 109 | Partial duplication of thumb phalanx (HP:0009944) | 1.97246598 |
| 110 | Turricephaly (HP:0000262) | 1.97046654 |
| 111 | Anterior segment dysgenesis (HP:0007700) | 1.96997622 |
| 112 | Accelerated skeletal maturation (HP:0005616) | 1.96682795 |
| 113 | Atrial fibrillation (HP:0005110) | 1.95623860 |
| 114 | Abnormality of Sharpey fibers (HP:0100685) | 1.95007333 |
| 115 | Abnormality of the foot musculature (HP:0001436) | 1.94316882 |
| 116 | Neck muscle weakness (HP:0000467) | 1.93079290 |
| 117 | Hydroxyprolinuria (HP:0003080) | 1.92761394 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 1.92761394 |
| 119 | Large hands (HP:0001176) | 1.92599534 |
| 120 | Duplicated collecting system (HP:0000081) | 1.92424131 |
| 121 | Hemiplegia (HP:0002301) | 1.91447500 |
| 122 | Male pseudohermaphroditism (HP:0000037) | 1.90828131 |
| 123 | Chondrocalcinosis (HP:0000934) | 1.90360800 |
| 124 | Gowers sign (HP:0003391) | 1.89216538 |
| 125 | Increased muscle lipid content (HP:0009058) | 1.89102851 |
| 126 | Nasolacrimal duct obstruction (HP:0000579) | 1.88629689 |
| 127 | Transposition of the great arteries (HP:0001669) | 1.87396143 |
| 128 | Abnormal connection of the cardiac segments (HP:0011545) | 1.87396143 |
| 129 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.87396143 |
| 130 | Partial duplication of the phalanx of hand (HP:0009999) | 1.87204225 |
| 131 | Shallow orbits (HP:0000586) | 1.87106255 |
| 132 | Ventricular arrhythmia (HP:0004308) | 1.86870355 |
| 133 | Aneurysm (HP:0002617) | 1.86337277 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 1.85690552 |
| 135 | Broad hallux (HP:0010055) | 1.84655131 |
| 136 | Vascular tortuosity (HP:0004948) | 1.84145806 |
| 137 | Absent toe (HP:0010760) | 1.83344777 |
| 138 | Ventricular tachycardia (HP:0004756) | 1.82873484 |
| 139 | Wide anterior fontanel (HP:0000260) | 1.81832994 |
| 140 | Patent foramen ovale (HP:0001655) | 1.81252658 |
| 141 | Hyperpituitarism (HP:0010514) | 1.81168130 |
| 142 | Areflexia of lower limbs (HP:0002522) | 1.80976111 |
| 143 | Dilatation of the ascending aorta (HP:0005111) | 1.80788843 |
| 144 | Rhabdomyolysis (HP:0003201) | 1.80210036 |
| 145 | Foot dorsiflexor weakness (HP:0009027) | 1.80011141 |
| 146 | Abnormality of incisor morphology (HP:0011063) | 1.78777365 |
| 147 | Hypoplastic ischia (HP:0003175) | 1.78541878 |
| 148 | Ulnar deviation of the wrist (HP:0003049) | 1.78332863 |
| 149 | Gingival overgrowth (HP:0000212) | 1.77630461 |
| 150 | Abnormality of the pulmonary veins (HP:0011718) | 1.77090775 |
| 151 | Limb-girdle muscle weakness (HP:0003325) | 1.76029541 |
| 152 | Sudden death (HP:0001699) | 1.75112315 |
| 153 | Abnormality of glycine metabolism (HP:0010895) | 1.73637675 |
| 154 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73637675 |
| 155 | Ventricular fibrillation (HP:0001663) | 1.73499060 |
| 156 | Obstructive sleep apnea (HP:0002870) | 1.73280007 |
| 157 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.73213497 |
| 158 | Synostosis involving the elbow (HP:0003938) | 1.72537057 |
| 159 | Humeroradial synostosis (HP:0003041) | 1.72537057 |
| 160 | EMG: neuropathic changes (HP:0003445) | 1.72441757 |
| 161 | Large for gestational age (HP:0001520) | 1.71948682 |
| 162 | Xerostomia (HP:0000217) | 1.71730061 |
| 163 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71647008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 5.96758789 |
| 2 | EPHA3 | 4.19390043 |
| 3 | TIE1 | 4.13855349 |
| 4 | CAMK1D | 3.78211764 |
| 5 | PDGFRA | 3.26510526 |
| 6 | NTRK1 | 2.75084489 |
| 7 | TTN | 2.73781957 |
| 8 | CAMK1G | 2.71278745 |
| 9 | TAF1 | 2.42152912 |
| 10 | TRIB3 | 2.28732618 |
| 11 | FGFR2 | 2.26679427 |
| 12 | NTRK3 | 2.15587553 |
| 13 | MUSK | 2.10854479 |
| 14 | KIT | 2.10032145 |
| 15 | TGFBR2 | 2.06891696 |
| 16 | DMPK | 2.04092536 |
| 17 | NTRK2 | 2.01431709 |
| 18 | PDK4 | 1.89372754 |
| 19 | PDK3 | 1.89372754 |
| 20 | PTK2B | 1.88052151 |
| 21 | MAPK12 | 1.85306198 |
| 22 | PIK3CA | 1.84157152 |
| 23 | EPHB1 | 1.75318946 |
| 24 | EPHB2 | 1.71088119 |
| 25 | PDGFRB | 1.63795504 |
| 26 | MET | 1.62706913 |
| 27 | LATS2 | 1.62143414 |
| 28 | MAPK15 | 1.62060835 |
| 29 | STK39 | 1.59610462 |
| 30 | BCKDK | 1.58048803 |
| 31 | PDK2 | 1.47245150 |
| 32 | ILK | 1.40488549 |
| 33 | STK38L | 1.39056290 |
| 34 | ZAK | 1.38595439 |
| 35 | MAPK7 | 1.34449528 |
| 36 | PAK2 | 1.31876425 |
| 37 | RIPK1 | 1.30249921 |
| 38 | DDR2 | 1.22879032 |
| 39 | PIK3CG | 1.15757295 |
| 40 | PKN1 | 1.15400774 |
| 41 | TYRO3 | 1.12917487 |
| 42 | DAPK3 | 1.09837942 |
| 43 | EEF2K | 1.08192954 |
| 44 | BCR | 1.06458855 |
| 45 | PINK1 | 1.05095450 |
| 46 | CDK9 | 1.05049846 |
| 47 | MARK1 | 1.03890750 |
| 48 | ROCK1 | 0.99756279 |
| 49 | PRKD3 | 0.97823882 |
| 50 | NLK | 0.96321541 |
| 51 | LMTK2 | 0.94954736 |
| 52 | FER | 0.88403662 |
| 53 | KSR2 | 0.86890421 |
| 54 | OXSR1 | 0.86744412 |
| 55 | MAPKAPK3 | 0.85997347 |
| 56 | STK11 | 0.85670440 |
| 57 | SGK2 | 0.84019636 |
| 58 | PNCK | 0.84000318 |
| 59 | AKT3 | 0.83759265 |
| 60 | CDC42BPA | 0.83677372 |
| 61 | MAP3K7 | 0.83509353 |
| 62 | FRK | 0.82372400 |
| 63 | MAPK4 | 0.80275882 |
| 64 | PRKAA2 | 0.79257796 |
| 65 | GSK3A | 0.77921196 |
| 66 | WNK1 | 0.76787495 |
| 67 | LATS1 | 0.74215525 |
| 68 | MAPKAPK5 | 0.72819074 |
| 69 | PHKG2 | 0.70568646 |
| 70 | PHKG1 | 0.70568646 |
| 71 | WNK4 | 0.69571592 |
| 72 | SIK1 | 0.68867629 |
| 73 | RPS6KA2 | 0.68779869 |
| 74 | PRKD1 | 0.67397147 |
| 75 | MAP2K1 | 0.66553672 |
| 76 | PRKCE | 0.66319505 |
| 77 | LIMK1 | 0.66148952 |
| 78 | ADRBK1 | 0.65489696 |
| 79 | GRK1 | 0.65236408 |
| 80 | AKT2 | 0.63889121 |
| 81 | GRK5 | 0.62821759 |
| 82 | ABL2 | 0.62361928 |
| 83 | MAP3K10 | 0.61593989 |
| 84 | CAMK1 | 0.61520699 |
| 85 | FGFR3 | 0.60529150 |
| 86 | CAMK2A | 0.60380442 |
| 87 | PAK3 | 0.60118254 |
| 88 | UHMK1 | 0.59367055 |
| 89 | PRKCH | 0.58143687 |
| 90 | RPS6KC1 | 0.56513443 |
| 91 | RPS6KL1 | 0.56513443 |
| 92 | CAMK2G | 0.55163424 |
| 93 | NEK9 | 0.55028620 |
| 94 | INSR | 0.54936991 |
| 95 | DYRK1B | 0.54456277 |
| 96 | GRK7 | 0.54160038 |
| 97 | ERBB4 | 0.53859023 |
| 98 | BMX | 0.52254678 |
| 99 | PTK2 | 0.51926951 |
| 100 | ROCK2 | 0.50843210 |
| 101 | MAP3K2 | 0.49873377 |
| 102 | RPS6KA6 | 0.48934198 |
| 103 | TNIK | 0.46687727 |
| 104 | CAMK2D | 0.46080774 |
| 105 | DAPK2 | 0.45625548 |
| 106 | MAPK10 | 0.45585649 |
| 107 | SGK223 | 0.44402157 |
| 108 | SGK494 | 0.44402157 |
| 109 | CASK | 0.44371136 |
| 110 | SGK3 | 0.43964681 |
| 111 | FGR | 0.43191547 |
| 112 | NUAK1 | 0.42623526 |
| 113 | CAMK2B | 0.42533582 |
| 114 | CSNK1A1L | 0.41018399 |
| 115 | PRKAA1 | 0.40914037 |
| 116 | MARK2 | 0.40799497 |
| 117 | MAPK13 | 0.40354409 |
| 118 | NEK6 | 0.40098860 |
| 119 | STK38 | 0.39912112 |
| 120 | RET | 0.39803432 |
| 121 | SGK1 | 0.38949034 |
| 122 | IGF1R | 0.38287570 |
| 123 | NME1 | 0.38221511 |
| 124 | PAK1 | 0.37446332 |
| 125 | STK24 | 0.37320261 |
| 126 | OBSCN | 0.36924982 |
| 127 | ZAP70 | 0.36819055 |
| 128 | RPS6KA3 | 0.36765053 |
| 129 | PTK6 | 0.35713143 |
| 130 | PRKACA | 0.35711912 |
| 131 | TRPM7 | 0.34715571 |
| 132 | CSK | 0.33816841 |
| 133 | FGFR1 | 0.33084349 |
| 134 | IRAK2 | 0.33015494 |
| 135 | TGFBR1 | 0.32711123 |
| 136 | PRKG2 | 0.32576505 |
| 137 | MAPKAPK2 | 0.32060782 |
| 138 | INSRR | 0.31614193 |
| 139 | FGFR4 | 0.30707394 |
| 140 | KDR | 0.30442709 |
| 141 | PRKG1 | 0.29950741 |
| 142 | ERN1 | 0.29349469 |
| 143 | PRKD2 | 0.28523191 |
| 144 | ABL1 | 0.27828785 |
| 145 | PRKACG | 0.27539222 |
| 146 | SRC | 0.26856477 |
| 147 | PAK4 | 0.26600716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.61501640 |
| 2 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.56258457 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.37883730 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.32894980 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.15843934 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.15019610 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.07370614 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.87979029 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.74290326 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69956814 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 2.06085754 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.99159453 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84519197 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.81890621 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.74775437 |
| 16 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.65600552 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.47305713 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.46369860 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.37846011 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36568644 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.32381776 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31357688 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.31082007 |
| 24 | Amoebiasis_Homo sapiens_hsa05146 | 1.28646209 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.28142559 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.21206412 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20831697 |
| 28 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20238431 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.19367722 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11338039 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10816608 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06239773 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.04265187 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.03883194 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03585112 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02933479 |
| 37 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.02205900 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01887481 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00969718 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.00735996 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98904123 |
| 42 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.98536262 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 0.95364377 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.94370704 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94193894 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93031893 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93031550 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92501061 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91915416 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 0.91730986 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.91343032 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90302696 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.89804054 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.89132066 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87283010 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86432901 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84889960 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83484858 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83307853 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81930673 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.80484164 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79544562 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79329347 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79256803 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.78945414 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.78011649 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77730814 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76485785 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.76329793 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76314101 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76010408 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.75747696 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75677732 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75209163 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.74405539 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73396114 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71652203 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71564704 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71520561 |
| 80 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71503845 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71164887 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70835117 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70143030 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69239042 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68835494 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68040430 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67793551 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67350934 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66753646 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64847571 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63923463 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63452836 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63351752 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62663574 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62573961 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61822679 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60986982 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60713807 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.58796269 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57705707 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.57539302 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56703277 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.55791701 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55748820 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55530351 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55134228 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55079154 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54973377 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54478055 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53986815 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53778536 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53571476 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53341805 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52948104 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.52948044 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52748082 |
| 117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48823736 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48571625 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47980581 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47744865 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46458024 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45989288 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45813616 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45492422 |
| 125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45320657 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45087317 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.44788738 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44313575 |
| 129 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43684060 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42621319 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41734438 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40435726 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39136187 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38587360 |
| 135 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36291961 |
| 136 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36203725 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33614670 |
| 138 | Morphine addiction_Homo sapiens_hsa05032 | 0.33137823 |
| 139 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32949028 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32127312 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29679364 |
| 142 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28304784 |
| 143 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.26608250 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26410400 |

